Research progress of direct thrombectomy and bridging therapy for acute ischemic stroke
10.3969/j.issn.1004-1648.2024.05.014
- VernacularTitle:急性缺血性卒中直接取栓与桥接治疗研究进展
- Author:
Na ZHUO
1
;
Yu FAN
;
Jianqi WEI
Author Information
1. 014040 内蒙古医科大学包头临床学院
- Keywords:
mechanical thrombectomy;
bridging therapy;
tenecteplase;
acute ischemic stroke
- From:
Journal of Clinical Neurology
2024;37(5):375-379
- CountryChina
- Language:Chinese
-
Abstract:
Endovascular mechanical thrombectomy is an important progress in the treatment of acute ischemic stroke,and early and timely endovascular mechanical thrombectomy can provide significant clinical benefits.The treatment mode of endovascular therapy after intravenous thrombolysis is bridging therapy,while the traditional bridging therapy may have limitations such as time delay and increased bleeding risk.In recent years,with the completion of several large scale randomized controlled trial,whether to bypass intravenous thrombolysis and directly perform mechanical thrombectomy has become a hot topic in the field of stroke treatment.In addition,the third generation of thrombolytic drug Tenecteplase has a more convenient way of administration,it also provides new ideas for bridging therapy.This article compares and analyzes the benefits and risks of direct mechanical thrombectomy therapy and bridging therapy based on relevant research that has been completed,aiming to provide reference for the correct selection of treatment methods for acute ischemic stroke patients.
